Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis
DOI: 10.1093/cid/ciag194Author: Milo Gatti et al.Published: 2026-3-18

Forum › Forums › Available Download: › DOI › Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis

DOI: 10.1093/cid/ciag194Author: Milo Gatti et al.Published: 2026-3-18

Tagged: 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • April 13, 2026 at 5:47 pm #1038
    randallz.floppingtonRandall Z.Floppington
    Participant

    Title: Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant
    Pseudomonas aeruginosa
    Infections: A Systematic Review and Meta-analysis
    Journal: Clinical Infectious Diseases
    Authors: Milo Gatti, Riccardo De Paola, Beatrice Giorgi, Federico Pea
    Date: 2026-3-18
    DOI: 10.1093/cid/ciag194
    Source: Oxford University Press (OUP)
    Source URL: https://doi.org/10.1093/cid/ciag194

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.